ASN
RYTM icon

Advisory Services Network’s Rhythm Pharmaceuticals RYTM Stock Holding History

Advisory Services Network’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.22K Buy
+37
New +$3.6K ﹤0.01% 4004
2025
Q4 		– Sell
-19
Closed -$1.92K – 3793
2025
Q3 		$1.92K Buy
+19
New +$1.76K ﹤0.01% 3809

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Advisory Services Network's RYTM Position: Q1 2026 in Review

Advisory Services Network opened a new position in Rhythm Pharmaceuticals (RYTM) in Q1 2026: 37 shares worth $3.22K. The stake represents ﹤0.01% of the portfolio and ranks #4004 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in RYTM as recently as Q3 2025.

Advisory Services Network first reported a position in RYTM in Q3 2025 and has held it in 2 quarters since. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Advisory Services Network held 37 shares of Rhythm Pharmaceuticals worth $3.22K as of Q1 2026.
  • Rhythm Pharmaceuticals was a new Advisory Services Network position in Q1 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4004 holding.
  • Advisory Services Network first reported a position in Rhythm Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.